Drug survival of IL‐23 and IL‐17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study — Leila Motedayen Aval (2025) | RDL Network
Drug survival of IL‐23 and IL‐17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study
Article 2025 en
Authors
LA
Leila Motedayen Aval
ZY
Zenas Z N Yiu
OA
Oras Alabas
Abstract
1 min read
Guselkumab and risankizumab have the most favourable drug survival for effectiveness, with comparable safety to ustekinumab, and more favourable than other BADBIR biologics. Longer drug survival may reduce treatment burden by minimizing treatment switches, clinic visits and disease flares, supporting IL-23p19 inhibitors as a practical long-term option for psoriasis.
Zenas Z N Yiu, G Becher, Brian Kirby, Philip Laws, Nick J. Reynolds, Catherine Smith, Richard B. Warren, Christopher Em Griffiths, Fiona Browne, Ian Evans, Elise Kleyn, Linda Lawson, Kathleen McElhone, Teena Mackenzie, Tess McPherson, Ruth Murphy, Caroline Owen, Eleanor Pearson, Josh Richards, Mark Lunt, A. David Burden, Oras Alabas, Simon Morrison, Shernaz Walton, Anthony Bewley, Shehnaz Ahmed, L. Jones, Charlotte Symons, Juliet N. Barker, Philip Hampton
K.J. Mason, Juliet N. Barker, Kay Hogan Smith, Philip Hampton, Mark Lunt, Kathleen McElhone, Richard Warren, Zenas Z N Yiu, Christopher Em Griffiths, A. David Burden
Shane Solanky, Salma Khan, Isabella Tosi, Hannah Dawe, Wan Xinyu, Rosa Andres Ejarque, Hira Bahadur Ale, Katarzyna Grys, Nick Dand, Satveer K. Mahil, Michael R. Barnes, Christopher Em Griffiths, Nick J. Reynolds, Catherine Smith, Richard B. Warren, Juliet N. Barker, Paola Di Meglio
Oras Alabas, K.J. Mason, Zenas Z N Yiu, Catherine Smith, Richard B. Warren, Christopher Em Griffiths, Juliet N. Barker, Simon Morrison, Anthony Bewley, Ian Evans, Christopher Griffiths, Shehnaz Ahmed, Brian Kirby, Elise Kleyn, Philip Laws, Philip Hampton, Oras Alabas, Kathleen McElhone, Zenas Z N Yiu, Teena Mackenzie, Tess McPherson,
Discussion(0)
No comments yet. Be the first to comment.